Lowenco Impilo

Lowenco

Lowenco at a glance

Lowenco develops, manufactures, markets, and installs large-scale modular ultra-low temperature (“ULT”) storage solutions for commercial biopharma, primarily targeting the drug substance market where large storage volumes are required.

Lowenco provides a disruptive and sustainable solution to an underserved market, offering a unique customer value proposition that is centered around superior technical performance, significantly lower cost of ownership, and outstanding energy efficiency when compared to traditional upright freezers.

Lowenco facts

Sector

Specialist Pharma Services

Impilo entry date

February 2022

HQ

Vamdrup, Denmark

Management team

Mikael Hoier (CEO)
Jesper Henriksen (CFO)

Impilo team

Magnus Edlund
Victor Steien
Henrik Nielsen
Olga Court-Payen

No of employees

52

Revenue development, EURm

2021
2022
2023

EBITDA development, EURm

2021
2022
2023

Investment thesis

  • Underlying exposure to the structurally growing and non-cyclical biopharmaceuticals market
  • Attractive niche growth market for ULT storage of high-volume drug substance
  • Disruptive solution to an underserved market dominated by upright freezer “farms”
  • Significant growth potential due to high penetration runway and underlying market growth

UN SDG Goals